FDA guidance
Bowel Cleansing for Colonoscopy: Efficacy and Safety Considerations for Developing New…
FDA guidance · Draft · issued Dec 10, 2021
Key facts
| Title | Bowel Cleansing for Colonoscopy: Efficacy and Safety Considerations for Developing New Products : Draft Guidance for Industry |
|---|---|
| Status | Draft |
| Issue date | Dec 10, 2021 |
| Center | Center for Drug Evaluation and Research |
| Issuing office | Center for Drug Evaluation and Research |
| Communication type | Guidance Document |
| Regulated product | Drugs |
| Docket number | FDA-2021-D-0406 |
| Comments close | Feb 10, 2022 |
| Open for comment | No |
| Document on fda.gov | fda.gov |
At a glance
- None Product codes referenced
- None Recognized standards referenced
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA guidance documents
FDA guidance documents describe the agency's current thinking on regulatory topics. Drafts are issued for comment before a final version is published.
Source: U.S. Food and Drug Administration (FDA), Guidance Documents